Terms: = Pancreatic cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
517 results:
1. The Effect of Intratumor Heterogeneity in pancreatic Ductal Adenocarcinoma Progression and Treatment.
Saleh O; Shihadeh H; Yousef A; Erekat H; Abdallh F; Al-Leimon A; Elsalhy R; Altiti A; Dajani M; AlBarakat MM
Pancreas; 2024 May; 53(5):e450-e465. PubMed ID: 38728212
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Signature of Human pancreatic cancer and Personalized Targeting.
Reshkin SJ; Cardone RA; Koltai T
Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
[TBL] [Abstract] [Full Text] [Related]
4. Twelve-month progression-free survival with sotorasib and panitumumab in kras G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
5. Droplet digital polymerase chain reaction detection of kras mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
[TBL] [Abstract] [Full Text] [Related]
6. Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
Kwan MC; Pitman MB; Fernandez-Del Castillo C; Zhang ML
Gut; 2024 Mar; 73(4):629-638. PubMed ID: 38195219
[TBL] [Abstract] [Full Text] [Related]
7. [Histopathologic diagnosis of solid and cystic pancreatic lesions with a focus on ductal adenocarcinoma : A vademecum for daily practice].
Esposito I; Yavas A; Häberle L
Pathologie (Heidelb); 2024 Feb; 45(1):5-18. PubMed ID: 38191761
[TBL] [Abstract] [Full Text] [Related]
8. Mass spectrometry analysis of intact protein
Xu M; Liu Z; Hu W; Han Y; Wu Z; Chen S; Xia P; DU J; Zhang X; Hao P; Xia J; Yang S
J Zhejiang Univ Sci B; 2024 Jan; 25(1):51-64. PubMed ID: 38163666
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
[TBL] [Abstract] [Full Text] [Related]
10. Precision medicine for kras wild-type pancreatic adenocarcinomas.
Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
[TBL] [Abstract] [Full Text] [Related]
12. Tissue processing of endoscopic ultrasound-guided fine-needle aspiration specimens from solid pancreatic lesions.
Notohara K; Nakamura K
J Med Ultrason (2001); 2024 Apr; 51(2):261-274. PubMed ID: 38051462
[TBL] [Abstract] [Full Text] [Related]
13. Endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions: a comprehensive review.
Iwashita T; Uemura S; Shimizu M
J Med Ultrason (2001); 2024 Apr; 51(2):219-226. PubMed ID: 38051460
[TBL] [Abstract] [Full Text] [Related]
14. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis.
Tamura T; Ashida R; Wan K; Shimokawa T; Kitano M
Pancreatology; 2024 Feb; 24(1):78-87. PubMed ID: 38042675
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and genomic characterisation of early-onset pancreatic cancer.
Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in pancreatic cancer.
Sellahewa R; Moghaddam SM; Lundy J; Jenkins BJ; Croagh D
Pancreas; 2023 Mar; 52(3):e188-e195. PubMed ID: 37751379
[TBL] [Abstract] [Full Text] [Related]
17. Mutation Analysis of pancreatic Juice and Plasma for the Detection of pancreatic cancer.
Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review.
Mattiolo P; Wang H; Basturk O; Brosens LAA; Hong SM; Adsay V; Scarpa A; Luchini C
J Clin Pathol; 2023 Nov; 76(11):740-746. PubMed ID: 37643836
[TBL] [Abstract] [Full Text] [Related]
19. RBPJ Deficiency Sensitizes pancreatic Acinar Cells to kras-Mediated pancreatic Intraepithelial Neoplasia Initiation.
Pan L; Mulaw MA; Gout J; Guo M; Zarrin H; Schwarz P; Baumann B; Seufferlein T; Wagner M; Oswald F
Cell Mol Gastroenterol Hepatol; 2023; 16(5):783-807. PubMed ID: 37543088
[TBL] [Abstract] [Full Text] [Related]
20. Current status of molecular diagnostic approaches using liquid biopsy.
Takahashi K; Takeda Y; Ono Y; Isomoto H; Mizukami Y
J Gastroenterol; 2023 Sep; 58(9):834-847. PubMed ID: 37470859
[TBL] [Abstract] [Full Text] [Related]
[Next]
